Division of Hepatobiliary and General Surgery, Department of Surgery, Humanitas Reseach Hospital, Humanitas University, Rozzano, Milan, Italy.
Division of Hepatobiliary and General Surgery, Department of Surgery, Humanitas Reseach Hospital, Humanitas University, Rozzano, Milan, Italy.
Surgery. 2018 Nov;164(5):1006-1013. doi: 10.1016/j.surg.2018.06.030. Epub 2018 Sep 5.
The superiority of anatomic resection compared with nonanatomic resection for hepatocellular carcinoma remains a matter of debate. Further, the technique for anatomic resection (dye injection) is difficult to reproduce. Anatomic resection using a compression technique is an easy and reversible procedure based on liver discoloration after ultrasound-guided compression of the tumor-feeding portal tributaries. We compared the oncologic efficacy of compression technique anatomic resection with that of nonanatomic resection.
Among patients with resected hepatocellular carcinoma, patients who underwent compression technique anatomic resection were matched 1-to-2 with nonanatomic resection cases based on the Child-Pugh class, Model for End-Stage Liver Disease score, cirrhosis, hepatocellular carcinoma number (1/>1), and hepatocellular carcinoma size (>30, 30-50, and >50 mm). The exclusion criteria were nonanatomic resection because of severe cirrhosis, major hepatectomy, 90-day mortality (0 compression technique anatomic resection), non-cancer-related death, and follow-up <12 months. A total of 47 patients who underwent compression technique anatomic resection were matched with 94 nonanatomic resection cases.
All patients were Child-Pugh A, and 53% were cirrhotic. Liver function tests and signs of portal hypertension were similar between the groups. There was 1 hepatocellular carcinoma in 81% of the patients, and the hepatocellular carcinoma was ≥30 mm in 68%. Patients undergoing anatomic resection with compression had better 5-year survival (77% vs 60%; risk ratio = 0.423; P = .032; multivariable analysis), less local recurrences (4% vs 20%; P = .012), and better 2-year local recurrence-free survival (94% vs 78%; P = .012). Nonlocal recurrence-free survival was similar between the groups. The compression technique anatomic resection group more often had repeat radical treatment for recurrence (68% vs 28%; P = .0004) and had better 3-year survival after recurrence (65% vs 42%; P = .043).
Compression technique anatomic resection appears to provide a more complete removal of the hepatocellular carcinoma-bearing portal territory. Local disease control and survival are better with compression technique anatomic resection than with nonanatomic resection.
解剖性肝切除术与非解剖性肝切除术相比具有优越性,但仍存在争议。此外,解剖性肝切除术(染料注射)的技术难以重现。基于超声引导下肿瘤供养门静脉分支压迫后肝脏变色,采用压迫技术的解剖性肝切除术是一种简单且可逆转的手术。我们比较了压迫技术解剖性肝切除术与非解剖性肝切除术的肿瘤学疗效。
在接受肝切除术的肝细胞癌患者中,根据 Child-Pugh 分级、终末期肝病模型评分、肝硬化、肝癌数量(1 个/多个)和肝癌大小(>30mm、30-50mm 和>50mm),将接受压迫技术解剖性肝切除术的患者与非解剖性肝切除术的患者进行 1:2 配对。排除标准是非解剖性肝切除因严重肝硬化、大范围肝切除、90 天死亡率(0 例采用压迫技术解剖性肝切除术)、非癌症相关死亡和随访<12 个月。共 47 例采用压迫技术解剖性肝切除术的患者与 94 例非解剖性肝切除术的患者相匹配。
所有患者均为 Child-Pugh A 级,53%为肝硬化。两组患者的肝功能检查和门静脉高压征象相似。81%的患者有 1 个肝癌,68%的肝癌≥30mm。行解剖性肝切除术加压迫的患者 5 年生存率(77%比 60%;风险比=0.423;P=0.032;多变量分析)更高,局部复发率(4%比 20%;P=0.012)更低,2 年局部无复发生存率(94%比 78%;P=0.012)更好。两组患者的非局部无复发生存率相似。压迫技术解剖性肝切除术组更常进行复发性根治性治疗(68%比 28%;P=0.0004),且复发后 3 年生存率更高(65%比 42%;P=0.043)。
压迫技术解剖性肝切除术似乎能更彻底地切除肝癌携带的门静脉区域。与非解剖性肝切除术相比,压迫技术解剖性肝切除术能更好地控制局部疾病和提高生存率。